Sign up
or
Register for free
BioNation
RSS
Companies
Jobs
Drugs
News
Home
News Center
Directory
Articles
Recent
News Center
Companies
Drugs
Marketed Drugs
Investigational Drugs
Jobs
Pharma & Biotech
Chemistry
Medtech
Healthcare
Food & Beverage
Finance
Shop
Market Research
Corporate Solutions
BioNation
Login
Email
Password
I've forgotten my password!
Create an account here!
Therapeutic Areas
Anti-Infective
Cardiovascular
Central Nervous System
Dermatology
Endocrine
Gastrointestinal
Genetic Disease
Genitourinary System
Hematology
Metabolic Disease
Immunomodulation
Musculoskeletal System
Oncology
Ophthalmology
Pain and Anesthesia
Respiratory System
Marketed Drugs Pain and Anesthesia
Pain
and Anesthesia Drug News
gw pharmaceuticals release: health canada grants full approval of sativex(r) for the treatment of sp
...
Aug 31 2010
ortho-mcneil-janssen pharmaceuticals, inc.'s pivotal phase 3 study compares tapentadol extended rele
...
Aug 30 2010
afferent pharmaceuticals announces data supporting potential utility of proprietary p2x3 antagonists
...
Aug 25 2010
nutra pharma corp. (nphc) begins drug registration process in india for nyloxin - a treatment for mo
...
Aug 19 2010
simcere pharmaceutical group announces sfda approval to manufacture and market palonosetron in china
...
Aug 12 2010
trigemina reports positive results with its lead compound ti-001 in a phase iia clinical trial for c
...
Aug 11 2010
qrxpharma pty ltd. announces positive phase 2 proof-of-concept data for moxduo(r)iv pain therapy
...
Aug 9 2010
Pain and Anesthesia
Jobs
Find an open position today!
Profile
Eisai’s Aloxi Injection receives FDA Approval while BioDelivery Sciences Seeks FDA Approval to Market BEMA Fentanyl
Treatment for chemotherapy's consequences and breackthrough cancer pain.
by Ronald Maldonado Rodriguez, PhD MSc , 07/04/2008
Selected
Regional Pain and Anesthesia Drug Revenues (milion USD)
CELECOXIB
2383.0
PFIZER INC
2009, Worldwide
TRANSDERMAL FENTANYL
888.0
JANSSEN PHARMACEUTICAL KK
2009, Worldwide
DICLOFENAC SODIUM
797.0
NOVARTIS AG
2009, Worldwide
DICLOFENAC SODIUM
792.0
NOVARTIS AG
2009, Rest Of The World
RIZATRIPTAN BENZOATE
574.5
MERCK AND CO INC
2009, Worldwide
ASPIRIN
453.6
BAYER AG
2009, Worldwide
SUMATRIPTAN + NAPROXEN SODIUM
85.8
GLAXOSMITHKLINE PLC
2009, Worldwide
CLONIDINE TRANSDERMAL
Aug 20, 2010
BARR PHARMACEUTICALS INC
ROCURONIUM BROMIDE
Jul 28, 2010
SAGENT PHARMACEUTICALS INC
OXYMORPHONE ER
Jul 22, 2010
IMPAX LABORATORIES INC
CLONIDINE TRANSDERMAL
Aug 20, 2010
BARR PHARMACEUTICALS INC
NABUMETONE
Jul 14, 2010
MYLAN INC
NARATRIPTAN HYDROCHLORIDE
Jul 7, 2010
ROXANE LABORATORIES INC
